glutathione and multiple myeloma Intracellular determines bortezomib cytotoxicity in cells A myeloma-targeting monoclonal antibody offers

A myeloma targeting monoclonal antibody offers new hope for treating multiple myeloma EurekAlert! A recent editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros and Aiolos, to treat multiple myeloma. Panel A shows the chemical structures Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance Nature Communications Frontiers Multi omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma Frontiers Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma

SKU: 2464650902 · From lagence-mr.com